Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Nusantara Sejahtera Raya Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Nusantara Sejahtera Raya Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp94 (market cap 7.92T, 33.27M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 24.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (33.27M versus 7.6K). Which is the better fit depends on your goals.

CNMADGNS
Market Cap
7.92T319B
Volume
33.27M7.6K
Lot
332.69K76
Turnover
3.13B1.74M
Average Price
94.01229.21
Value
3.13B1.74M
Indicative Equilibrium Price
95232
Indicative Equilibrium Volume
214.4K200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CNMA
View details
DGNS
View details

About Nusantara Sejahtera Raya Tbk.

PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.

Read more on CNMA

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS